554.50
-1.16%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About MedCap AB (publ)
Its shares trade on Nasdaq Stockholm under the ticker MCAP.ST. It has been listed since 4 July 2006. In the fiscal year to 31 December 2025, it reported revenue of SEK 2.11bn and net income of SEK 219.8m. At that date it held total assets of SEK 2.61bn and shareholders' equity of SEK 1.45bn.
MedCap AB is an investment company engages in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 4 Jul 2006
- Employees
- 287
- Website
- medcap.se ↗
Leadership
Pay as last reported
- Mr. Karl TobiesonChairman of the Board, since 2008SEK 425,000
- Mr. Anders DahlbergChief Executive OfficerSEK 6.7m
- Ms. Kristina EkbladChief Financial Officer
- Mr. Sebastian BacklundInvestment Manager
- Mr. Lars AngmanInvestment Manager
- Mr. Otto AnkarcronaIndependent Director
- Ms. Malin EnarsonIndependent Director
- Mr. David JernIndependent Director, since 2008SEK 170,000
- Ms. Lena SoderstromIndependent DirectorSEK 117,000
- Ms. Anna TornerIndependent DirectorSEK 117,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MedCap AB has a strong market presence in the healthcare industry, with a solid reputation for delivering innovative products and services.
- The company has a diverse portfolio, offering a wide range of medical devices and technologies that cater to different areas of healthcare.
- MedCap AB has a highly skilled workforce, consisting of experienced professionals and scientists who contribute to the development of cutting-edge solutions.
Weaknesses
- The company faces intense competition from other players in the market, which puts pressure on maintaining market share and profitability.
- MedCap AB relies heavily on external suppliers for the raw materials required in its production process, making it vulnerable to supply chain disruptions.
- The company's overall financial performance has seen some fluctuations, indicating a need for better financial management strategies.
Opportunities
- The growing demand for advanced medical devices and technologies presents an opportunity for MedCap AB to expand its product offerings and capture a larger market share.
- Expanding into emerging markets, where there is a rising need for healthcare solutions, could provide MedCap AB with significant growth opportunities.
- Collaborating with research institutions and healthcare organizations can facilitate the development of innovative solutions and strengthen the company's position as a market leader.
Threats
- Changes in regulations and compliance requirements within the healthcare industry can pose challenges and increase operational costs for MedCap AB.
- The emergence of new competitors and disruptive technologies could impact market share and potentially render some of MedCap AB's existing products obsolete.
- Global economic uncertainties and fluctuations in currency exchange rates can affect the company's international operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.